Announcements Trials
Browse Landscape

Phase

Phase NA 70Phase 2 14Phase 3 8Phase 1/2 4Phase 2/3 3Phase 4 2Phase 1 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1522OTHER 381NIH 99NETWORK 5UNKNOWN 2OTHER_GOV 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 6Lymphoma, B-Cell 5Uveal Melanoma 4Esophageal Neoplasms 4Colorectal Neoplasms 4Recurrence 3Polycystic Ovary Syndrome 3Neoplasms, Plasma Cell 3Multiple Myeloma 3Hematologic Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Follicular 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER_GOV × Neoplasms × Clear all
NCT04902313 2026-02-03

CROP

Linkoeping University

Phase 1 Completed
40 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT04087252 2020-04-15

An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment

Henan Cancer Hospital

Phase 1 Unknown
30 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡